You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 9, September 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  LETTERS TO THE EDITOR
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Improvement in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Following {gamma}-Globulin Infusion

P. A. Van Doorn; M. Vermeulen
Department of Neurology University Hospital Dijkzigt Dr Molewaterplein 40 3015 GD Rotterdam, the Netherlands

Arch Neurol. 1987;44(9):897-898.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Albala and his colleagues reported the improvement of neurologic function in one patient with a chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) following {gamma}-globulin infusion.1 The rationale for this treatment was the beneficial treatment response following {gamma}-globulin infusion in patients with idiopathic thrombocytopenic purpura and myasthenia gravis.

The rationale could also have been the reported beneficial response in patients with CIDP, since Vermeulen et al2 described improvement after fresh-frozen plasma and {gamma}-globulin infusion in patients with CIDP.

In this report,2 13 of 17 patients with CIDP improved after infusion of fresh-frozen plasma. Nine patients had {gamma}-globulin infusions, and eight patients improved. The first signs of improvement were seen within eight days of the onset of treatment. None of these patients had spontaneous remissions for two months before these infusions, and none had immunosuppressive treatment during the infusions.

We agree with Albala and his colleagues that a . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.